13 noviembre 2014
A new approach to block the KRAS oncogene, one of the most frequently mutated genes in human cancer, has been developed by researchers. The approach offers another route to attack KRAS, which has proven to be an elusive and frustrating target for drug developers.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/fYTSsUhfdnQ/141113123320.htm
